RESUMO Objetivo: Determinar a frequência de dor no quadril em atletas fisiculturistas durante três competições de fisiculturismo. Métodos: Este estudo avaliou fisiculturistas recrutados em três competições de fisiculturismo durante o ano de 2016. Termo de consentimento foi obtido de todos os participantes, e também foi obtido a aprovação do CEP. Rotina de treinos, condição de saúde, nível de sucesso nas competições, antecedente de dor no quadril ao exame físico foram avaliados. Resultados: Um total de 113 fisiculturistas foram avaliados, com idade e IMC médio de 30.5 ± 8.65 anos e 25.2 ± 3.65 kg/m2, respectivamente. O valor médio de flexão, adução, abdução, rotação interna, rotação externa do quadril, e distância entre o joelho e a mesa de exame (distância FABERE) foi de 116 ± 13, 23 ± 8, 71 ± 12, 40 ± 10, 36 ± 9 e 19 ± 4, respectivamente. Oito (7%) participantes apresentavam dor no quadril dentro da última semana antes de serem examinados, e apenas dois (1.7%) apresentavam sinal do impacto anterior do quadril à manobra de flexão adução e rotação interna. A dor no quadril não afetou o treinamento físico e a performance dos atletas que reportaram dor no quadril. Conclusão: Atletas sintomáticos continuaram o programa de treinamento mesmo na presença de dor no quadril. A frequência de dor no quadril de atletas fisiculturistas é alta e pode ter sido subestimada neste estudo. Nível de Evidência IV, Série de casos.

ABSTRACT Objective: To determine the frequency of hip pain in competitive bodybuilders over three different bodybuilding competitions. Methods: This study evaluated bodybuilders recruited from three competitions during the year of 2016. All participants provided their informed consent and the study received IRB approval. Training routine, health condition, level of success on competitions, history of hip pain and physical examination of the hip were evaluated. Results: 113 bodybuilders were evaluated, mean age was 30.5 ± 8.65 years and mean BMI was 25.2 ± 3.65 kg/m2. Mean values for hip flexion, adduction, abduction, internal rotation, external rotation and distance between the knee and the table (FABER distance) were 116 ± 13, 23 ± 8, 71 ± 12, 40 ± 10, 36 ± 9 and 19 ± 4, respectively. Eight (7%) participants presented hip pain within the week prior to examination and only 2 (1,7%) presented with anterior impingement sign. None of the athletes who reported hip pain interrupted their physical training or performance. Conclusion: Symptomatic athletes continued their training program under the presence of hip pain. The frequency of hip pain among bodybuilders is high and may be underestimated in this study. Level of Evidence IV, Case series.

OBJECTIVES: This study aimed to correlate a higher Pelvic-Trochanteric Index (PTI) with an increased varus of the femoral neck with greater trochanteric pain syndrome (GTPS). The secondary objective was to check whether the pelvic width changes with age. METHODS: A prospective study was conducted to compare female patients diagnosed with GTPS (case group) with asymptomatic female participants (control group) from March 2011 to June 2017. On an anteroposterior pelvic radiograph, lines were drawn by two radiologists, and the PTI (ratio of the distance between the greater trochanters and distance between the iliac crests) was defined and the femoral neck-shaft angle was measured. RESULTS: Data collected based on radiographs of 182 female patients (cases) and 150 female participants (controls) showed that the mean PTI was 1.09 (SD=0.01) in the case group and 1.07 (SD=0.01) in the control group (p<0.05), regardless of age. The distance between iliac crests increased with age (p<0.05) in symptomatic and asymptomatic individuals. It was also found that the mean femoral neck-shaft angle was 130.6° (SD=0.59) and progression of the varus angulation occurred with age in both groups, with a significance level of 5%. CONCLUSIONS: The PTI was higher in patients with GTPS. The femoral neck-shaft angle does not differ between individuals with and without GTPS; however, it does decrease with age. The pelvic width tends to increase with aging in symptomatic or asymptomatic individuals; therefore, the increase in the pelvic width and decrease in the femoral neck-shaft angle can be interpreted as normal in aging women, which could alter the biomechanics of the hips and pelvis.

RESUMO Objetivo: Verificar se o Hylan G-F20 melhora os resultados da lavagem e injeção de triancinolona na osteoartrite do quadril (OAQ). Métodos: 82 pacientes com HOA Kellgren e Lawrence graus II e III foram randomizados: lavagem e triamcinolona (G0); lavagem, triancinolona e 2 mL de Hylan G-F20 (G1); lavagem, triamcinolona e 4 mL de Hylan G-F20 (G2); lavagem, triancinolona e 6 mL de Hylan G-F20 (G3). A escala visual analógica (EVA), amplitude de movimento (ADM), questionários Womac e Lequesne foram obtidos no início, um, três, seis e doze meses após a injeção. Resultados: Todos os grupos apresentaram melhora clinicamente relevante (> 20%) entre o início e o primeiro mês, mantendo resultados subjetivos durante o estudo (p <0,001). Não foram encontradas diferenças entre os grupos nas avaliações subjetivas (p > 0,05). A flexão aumentou no G2 e G3 até um ano (p = 0,028). A rotação externa melhorou nos grupos Hylan no primeiro mês, mantendo os resultados até um ano (G1, p = 0,041; G2, p = 0,007), enquanto G0 nunca melhorou (p = 0,336). Conclusão: Lavagem do quadril e injeção de triancinolona, com ou sem Hylan, melhoram a dor, função e qualidade de vida até um ano na OAQ. Hylan pode melhorar a ADM até um ano. Nível de evidência IB, Ensaio clínico randomizado.

ABSTRACT Objective: To verify whether the use of Hylan G-F20 improves saline lavage and triamcinolone injection results in the treatment of hip osteoarthritis (HOA). Methods: 82 patients with HOA categorized as grades II and III severity, according to Kellgren and Lawrence criteria, were randomized into the groups: lavage and triamcinolone (G0); lavage, triamcinolone, and 2 mL of hylan G-F20 (G1); lavage, triamcinolone, and 4mL of hylan G-F20 (G2); lavage, triamcinolone, and 6mL of hylan G-F20 (G3). The VAS, range of motion (ROM), WOMAC, and Lequesne questionnaires were administered at baseline, one, three, six, and twelve months post-injection. Results: All groups showed clinically relevant improvements (> 20%) between baseline and first month post-injection, maintaining subjective results throughout the study period (p < 0.001). We found no differences between groups in any subjective evaluations (p > 0.05, for all). G2 and G3 obtained improved flexion results up to a year (p = 0.028). Hylan groups presented an improved external rotation since the first postoperative month and maintained the results up to a year (G1, p = 0.041; G2, p = 0.007), whereas G0 showed no improvement (p = 0.336). Conclusion: Hip lavage and triamcinolone injection, with or without the use of hylan, improves pain, function, and quality of life up to a year in HOA. Hylan may improve ROM up to one year. Level of Evidence IB, Randomized clinical trial.

OBJETIVOS: Avaliar os resultados funcionais iniciais e o índice de complicações precoces das artroplastias totais do quadril cerâmica-cerâmica em pacientes que convivem com o HIV e apresentam osteonecrose da cabeça femoral. MÉTODO: Doze pacientes HIV+ com diagnóstico de osteonecrose da cabeça do fêmur incongruente foram avaliados através de critérios clínicos, laboratoriais, pela escala funcional WOMAC antes e após o tratamento com substituição articular. RESULTADOS: Observamos que 83,3% dos indivíduos faziam uso de inibidores de protease, 75% apresentavam dislipidemia e 66,6% síndrome lipodistrófica, a melhora na evolução no escore WOMAC foi estatisticamente significativa para seis e 12 meses de pós-operatório em comparação com o escore pré-operatório e não observamos complicações secundárias a esse procedimento. CONCLUSÃO: A artroplastia total do quadril com implante de cerâmica-cerâmica para o tratamento da necrose avascular do quadril nessa parcela da população é opção cirúrgica adequada, apresenta melhora funcional inicial significativa e baixo índice de complicação precoce.

OBJECTIVES: To evaluate the initial functional results and early complication rate of ceramic-ceramic total hip replacements among patients living with HIV who presented osteonecrosis of the femoral head. METHOD: Twelve HIV-positive patients with a diagnosis of osteonecrosis of the incongruent femoral head were evaluated using clinical and laboratory criteria and the WOMAC functional scale before and after treatment with joint replacement. RESULTS: We observed that 83.3% of the subjects were taking protease inhibitors, 75% had dyslipidemia and 66.6% had lipodystrophy syndrome. The improvement over the evolution of the WOMAC score was statistically significant at six and twelve months after the operation, in comparison with the preoperative score. We did not observe complications secondary to this procedure. CONCLUSION: Total hip arthroplasty with a ceramic-ceramic implant for treating avascular necrosis of the hip is an appropriate surgical option for this portion of the population. It provides a significant initial functional improvement and a low early complication rate.